Phase 1 Diarrhea-predominant irritable bowel syndrome Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome

Diarrhea-predominant irritable bowel syndrome

Xiyuan Hospital of China Academy of Chinese Medical Sciences60 enrolled1 locationNCT06737666

Completed

Phase 1

A three-part, double-blind, placebo-controlled, Phase I/Ib study of the safety, tolerability and pharmacokinetics of single and multiple ascending doses of IMU-856 in healthy volunteers and patients with Celiac disease

Diarrhea-predominant irritable bowel syndrome

Immunic Australia Pty Ltd120 enrolled8 locationsACTRN12620000901909